Nutrigenomics Market Size, Share and Global Trend By Application (Diabetes, Obesity, Gastrointestinal, Woman health, Neurological, Others) and Regional Forecast, 2024-2032

Nutrigenomics is one of the applications of genomics, which deals with the study of the effect of nutrition on metabolic pathways and gene expression. Nutrigenomics centers around understanding the interaction between genome and the nutrients at the molecular level to determine how specific nutrient and dietary regime can affect human health. Nutrigenomics is expected to provide strong support to the emerging new treatment procedures and methods.

Increased research on genomics and the emergence of nutrigenomics services have paved its way for numerous strategic collaboration between major players. For example, in July 2017, DNAfit launched five new DNA-based products developed in collaboration with Helix, which launched the first online marketplace of DNA-powered products. The global nutrigenomics market is expected to witness huge growth owing to the increasing prevalence of lifestyle diseases like diabetes and obesity.

To gain extensive insights into the market, Request for Customization

The global nutrigenomics market is projected to witness growth due to the presence of certain favorable factors such as rapid adoption of genomics and personalized medicine, increasing prevalence of lifestyle diseases like diabetes and obesity, increasing awareness regarding preventative healthcare, improved disease management, and various lucrative pricing strategies implemented by market players.

According to WHO, in 2016, an estimated 600 million adults in the world suffered from obesity, which is likely to fuel the market. Leading nutrigenomics companies in developed and developing countries to offer door to door services, which is expected to accelerate the adoption of nutrigenomics testing during the forecast period.

According to the Academy of Nutrition and Dietetics, significant research is needed before nutrigenomics, or personalized nutrition can deliver the expected benefits. One of the limitations of nutrigenomics is that the methods used to prescribe dietary intake based on genomic data are imprecise.

Additionally, since nutrigenomics depends on genetic tests by samples from identified population, ethical and legal implications like non-medical use of genetic data, the confidentiality of the customer’s genetic information may inhibit the growth in the global nutrigenomics market.

Key Players Covered

The nutrigenomics industry is considered to be a fragmented market, as there are many local and regional players operating across the globe. Key players operating in the global nutrigenomics market are 23andMe Inc., DNAfit, GX Sciences Inc., Vitagene, Nutrigenomix, Mapmygenome, Gini Health, geneOmbio, Xcode Life and others.

SEGMENTATION

Among the application, the obesity segment is expected to hold a larger portion of the global nutrigenomics market during the projected period owing to the rise in obese population, rising prevalence of lifestyle-related diseases, and growing awareness among the population about the health risk associated with obesity.

Key Insights

• Regulatory scenario in key countries


• Key strategies of leading market players


• Key start-ups with their funding overview


• Pricing analysis of key market players


• Key mergers and collaborations

Regional Analysis

North America is anticipated to dominate the global nutrigenomics market over the forecast period owing to the rapid adoption of personal genomics, increase in a number of services providers, and rising prevalence of lifestyles related diseases. The nutrigenomics market in Europe is projected to expand during the forecast duration due to increased research, strategic collaborations, and active government support. Asia Pacific is expected to witness a remarkable growth in the nutrigenomics industry owing to the larger patient pool suffering from lifestyle disease combined with lucrative pricing strategies by various start-up companies in these regions.

Key Industry Developments

• In June 2018, 23&Me collaborated with GlaxoSmithKline that will focus on research and development of innovative medicine and potential cures using human genetics as basis for discovery.


• In February 2018, 23&Me launched The Global Genetic Project to enrich understanding of human genetic diversity and power insights into health conditions that may impact populations that are underrepresented in genetic research.


• In June 2017, DNAFit and Vita Mojo teamed up to create the world’s most personalized restaurant menu, exclusively designed for each customer’s DNA.